Delivery Order SPE2DB20D2104-SPE2DB23FV01V

Award Date 8/23/23
Potential Completion Date 8/24/23
Potential Value $48K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $7,735.40 and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $51,614.77 and a performance period through December 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $114,787.52, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a completion date of July 11, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $42,929.04 and covers the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract is a Firm Fixed Price arrangement, with an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The total ceiling value of the contract is $108,666.14, with a performance period through October 10, 2024. This award is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The contract has a ceiling value of $66,409.10 and an ultimate completion date of January 5, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a ceiling value of $24,233.84 and an ultimate completion date of March 29, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The order has a ceiling value of $9,940.72 and a performance period ending on August 19, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $319,802.40 and covers the delivery of STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a period of performance through March 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,207.68 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV01V
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The contract has a ceiling value of $48,478.40 and an ultimate completion date of August 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:41 AM